Richardson Electronics Ltd

RELLNASDAQ · USD
16.85USD+0.40 (+2.41%)
669

Richardson Electronics Ltd (RELL) Wheel Strategy

RELL wheel strategy scan found 4 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 93.3%.

Read more

Running a RELL wheel strategy lets you generate consistent premium income on Richardson Electronics Ltd while setting your own entry and exit prices on the underlying. Richardson Electronics Ltd's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own RELL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best RELL wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on RELL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable RELL wheel from a losing one.

Richardson Electronics, Ltd. engages in the power and microwave technologies, customized display solutions, and healthcare businesses in North America, the Asia Pacific, Europe, and Latin America. Its Power and Microwave Technologies Group segment provides engineered solutions, power grid and microwave tubes, and related consumables; technical services for microwave and industrial equipment; and power conversion and RF and microwave component for broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar, and radiation oncology applications.

The company's Canvys segment provides custom display solutions, such as touch screens, protective panels, all-in-one computers, custom enclosures, specialized cabinet finishes, application specific software packages, and certification services to corporate enterprise, financial, healthcare, industrial, and medical original equipment manufacturer markets. Its Healthcare segment manufactures and distributes diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; MRI coils, cold heads, and RF amplifiers; hydrogen thyratrons, klystrons, and magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions, as well as offers CT service training. It serves hospitals, medical centers, asset management companies, independent service organizations, and multi-vendor service providers. The company's products are used to control, switch, or amplify electrical power signals, as well as used as display devices in alternative energy, healthcare, aviation, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company was founded in 1947 and is headquartered in LaFox, Illinois.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the RELL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your RELL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202615.00$0.05$1.15-0.323035%60.0%93.3%97
Dec 18, 202615.00$0.70$2.35-0.329335%50.3%61.5%109
Dec 18, 202612.50$0.30$1.15-0.209335%66.2%36.1%256
Mar 19, 202712.50$0.55$1.53-0.2118435%56.3%24.2%10

As of September 16, 2026

Run the Wheel on RELL With Confidence

Find the best RELL wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial